MD MBA - HCA Healthcare Executive Officer
| 0J1R Stock | 333.91 0.63 0.19% |
Executive
MD MBA is Executive Officer of HCA Healthcare
| Age | 58 |
| Address | One Park Plaza, Nashville, TN, United States, 37203 |
| Phone | 615 344 9551 |
| Web | https://hcahealthcare.com |
HCA Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.1139 % which means that it generated a profit of $0.1139 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.8244 %, meaning that it generated $0.8244 on every $100 dollars invested by stockholders. HCA Healthcare's management efficiency ratios could be used to measure how well HCA Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, HCA Healthcare's Total Assets are comparatively stable compared to the past year. Total Current Assets is likely to gain to about 17.2 B in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 218.5 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| BjornOsvald Skandsen | Systemair AB | 52 | |
| Claire Walsh | Learning Technologies Group | N/A | |
| Bjorn Walther | Systemair AB | N/A | |
| Evgeny An | Air Products Chemicals | N/A | |
| Marco Zampetti | Gruppo MutuiOnline SpA | 55 | |
| Veronika Jung | Wizz Air Holdings | N/A | |
| Tracey McCann | Ryanair Holdings plc | 51 | |
| Eric Guter | Air Products Chemicals | N/A | |
| Owain Jones | Wizz Air Holdings | N/A | |
| Matteo Fregni | Wizz Air Holdings | N/A | |
| William Pellicciotti | Air Products Chemicals | 46 | |
| Geoff Achilles | Air Products Chemicals | N/A | |
| Janni Weber | Systemair AB | 42 | |
| Rehan Ashraf | Air Products Chemicals | N/A | |
| Katie McDonald | Air Products Chemicals | N/A | |
| Alessio Santarelli | Gruppo MutuiOnline SpA | N/A | |
| Alberto Furia | Gruppo MutuiOnline SpA | N/A | |
| Mudassar Ali | Systemair AB | N/A | |
| Giuseppe Spagoni | Gruppo MutuiOnline SpA | N/A | |
| Peter Larkin | Ryanair Holdings plc | N/A | |
| Carol Sharkey | Ryanair Holdings plc | 50 | |
Management Performance
| Return On Equity | 0.82 | |||
| Return On Asset | 0.11 |
HCA Healthcare Leadership Team
Elected by the shareholders, the HCA Healthcare's board of directors comprises two types of representatives: HCA Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HCA. The board's role is to monitor HCA Healthcare's management team and ensure that shareholders' interests are well served. HCA Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HCA Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Rutherford, Executive CFO | ||
| Kathleen JD, Senior Officer | ||
| Samuel Hazen, CEO Director | ||
| Greg Lowe, President Division | ||
| Christopher Wyatt, Principal VP | ||
| Terence Arkel, Chief Division | ||
| Chad Wasserman, Senior Officer | ||
| MD Frist, Founder Emeritus | ||
| Michael McAlevey, Executive Officer | ||
| Charles Gressle, President Division | ||
| Dan Miller, President Division | ||
| Deborah Reiner, Senior Communications | ||
| Martin Paslick, Senior Officer | ||
| Timothy McManus, President Group | ||
| Phillip Billington, Senior Services | ||
| Jeffrey Cohen, Senior Relations | ||
| MD MBA, Executive Officer | ||
| Frank CFA, Vice Relations | ||
| Joseph III, Senior Officer | ||
| Erol FACHE, President Group | ||
| Thomas Frist, Founder Emeritus | ||
| Michael Marks, Senior Finance | ||
| Jim Brown, Chief Center | ||
| Jon Foster, Executive COO | ||
| Brian Cook, President Division | ||
| Jennifer Berres, Senior Officer | ||
| Charles Hall, Pres Group |
HCA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HCA Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.82 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 129 B | |||
| Shares Outstanding | 344.16 M | |||
| Shares Owned By Insiders | 29.31 % | |||
| Shares Owned By Institutions | 65.91 % | |||
| Price To Sales | 1.63 X | |||
| Revenue | 70.6 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for HCA Stock Analysis
When running HCA Healthcare's price analysis, check to measure HCA Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HCA Healthcare is operating at the current time. Most of HCA Healthcare's value examination focuses on studying past and present price action to predict the probability of HCA Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HCA Healthcare's price. Additionally, you may evaluate how the addition of HCA Healthcare to your portfolios can decrease your overall portfolio volatility.